For instance, CLDN1 was reported to induce cell migration and invasion through activation of the c-Abl-ERK signaling pathway in human liver cells [32]. Parallelly, it is revealed that CLDN18 coupled with EGFR/ERK signaling contributes to the malignant potential of bile duct cancer [33]. Here, ABL1 is linked to bile duct cancer.